🇺🇸 Twice Daily Tacrolimus in United States

Twice Daily Tacrolimus (Twice Daily Tacrolimus) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Twice Daily Tacrolimus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Twice Daily Tacrolimus approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Twice Daily Tacrolimus in United States?

University of Saskatchewan is the originator. The local marketing authorisation holder may differ — check the official source linked above.